Ureidopropionase, beta (UPB1) Peptid
Kurzübersicht für Ureidopropionase, beta (UPB1) Peptid (ABIN937005)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- AVVISNSGAV LGKTRKNHIP RVGDFNESTY YMEGNLGHPV FQTQFGRIAV
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of UPB1 antibody,
Alternative Names: UPB1 control peptide, UPB1 antibody Blocking Peptide, Anti-UPB1 Blocking Peptide, Ureidopropionase Beta Blocking Peptide, BUP1 Blocking Peptide, UPB1, UPB-1, UPB 1, UPB-1 Blocking Peptide, UPB 1 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- UPB1 (Ureidopropionase, beta (UPB1))
-
Hintergrund
- UPB1 is a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.
-
Molekulargewicht
- 42 kDa
Target
-